Molecular Pathology of Rare Diseases
MolPath-RD
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (1)
2021
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48